Bacteriophages as tools for vaccine and drug development

Expert Review of Vaccines

Volumn 4, Issue 1, 2005, Pages 5-7

  Manoutcharian, Karen ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGE DNA; DNA VACCINE; EPITOPE; GENOMIC DNA; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; RNA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VACCINE;

ALZHEIMER DISEASE; ANTIBIOTIC RESISTANCE; ANTIGENICITY; BACTERIOPHAGE; BACTERIOPHAGE LAMBDA; BACTERIOPHAGE M13; BACTERIOPHAGE PHI X 174; BIOTECHNOLOGY; CELLULAR IMMUNITY; COMBINATORIAL LIBRARY; COST EFFECTIVENESS ANALYSIS; CYSTICERCOSIS; DNA LIBRARY; DNA PACKAGING; DRUG DESIGN; DRUG RESEARCH; EDITORIAL; GENOME; HEAT TOLERANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE FUNCTION; NONHUMAN; PARKINSON DISEASE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; VACCINATION; VIRUS CULTURE;

ANIMALS; BACTERIOPHAGES; CLINICAL TRIALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GENE LIBRARY; GENETIC VECTORS; HUMANS; PEPTIDE LIBRARY; VACCINES, DNA;

EID: 14744272731     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.4.1.5     Document Type: Editorial

References (11)

1. Zinkernagel RM. Immunity, immunopathology and vaccines against HIV? Vaccine 20, 1913-1917 (2002).
2. Benhar I. Biotechnological applications of phage and cell display. Biotechnol. Adv. 19, 1-33 (2004).
3. Arap W, Kolonin MG, Trepel M et al. Steps toward mapping the human vasculature by phage display. Nature Med. 8(2), 121-127 (2002).
4. Manoutcharian K, Gevorkian G, Cano A, Almagro JC. Phage-displayed biomolecules as preventive and therapeutic agents. Curr. Pharmac. Biotech. 2, 217-223 (2001).
5. Clark JR, March JB. Bacterial viruses as human vaccines? Expert Rev. Vaccines 3(4), 463-476 (2004).
6. + T-cell function in vivo in HIV-infected patients as measured by bacteriophage phi 174 immunization. J. Infect. Dis. 182, 435-441 (2000).
7. Thiel K. Old dogma, new tricks - 21st century phage therapy. Nature Biotech. 22(1), 31-36 (2004).
8. Krag DN, Fuller SP, Oligino L et al. Phage-displayed random peptide libraries in mice: toxicity after serial panning. Cancer Chemother. Pharmacol. 50(4), 325-332 (2002).
9. Manoutcharian K, Díaz-Orea A, Gevorkian G et al. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet. Immunol. Immunopath. 99, 11-24 (2004).
10. Petrenko VA, Smith GP. Phage from landscape libraries as substitute antibodies. Prot. Engin. 13(8), 589-592 (2000).
11. Carrera MRA, Kaufmann GF, Mee JM et al. Treating cocaine with viruses. Proc. Natl Acad. Sci. USA 101(28), 10416-10421 (2004).